Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients-Reference-Cited by-同舟云学术

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

Published:2003-04-07 Issue:8 Volume:100 Page:4712-4717
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Hodi F. S.,Mihm M. C.,Soiffer R. J.,Haluska F. G.,Butler M.,Seiden M. V.,Davis T.,Henry-Spires R.,MacRae S.,Willman A.,Padera R.,Jaklitsch M. T.,Shankar S.,Chen T. C.,Korman A.,Allison J. P.,Dranoff G.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference55 articles.

1. Human tumor antigens recognized by T lymphocytes.

2. New Paths in Human Cancer Serology

3. Human neoplasms elicit multiple specific immune responses in the autologous host.

4. CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production

5. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

Cited by 860 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects;Oncologie;2024-01-01

2. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024

3. Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview;Medical Oncology;2023-12-29

4. Lactose blocks intercellular spreading of Galectin-1 from cancer cells to T-cells and activates tumor immunological control;2023-12-20

5. Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies;Translational Oncology;2023-12